
This review explores metabolic and cardiovascular changes during the menopausal transition, addressing the roles of ovarian ageing, chronological aging, and related risk factors. It discusses the impact of premature or early menopause, surgical menopause, and menopausal symptoms on cardiovascular risk. The review also considers strategies for risk reduction, including menopausal hormone therapy, and explores potential novel treatments.
Like
Save
Share